Do the benefits of the new OSHA HIV/HBV standard justify the costs?
On December 6, 1991, OSHA published its "final standard" for controlling occupational exposure to HIV and HBV. While the main thrust of the standard is sound, in some physicians' assessment, some of the detailed emphasis may be misdirected. They fear that the burdens imposed by the standard may be greater than the benefits derived from it. "Health Law" is a regular feature of Physician Executive contributed by Epstein, Becker, and Green. Mark Lutes of the firm's Washington, D.C., offices serves as editor for the column.
Weissburg
D J
DJ
D001769:Blood; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006268:Health Facilities / Q000331:legislation & jurisprudence*; D006509:Hepatitis B / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017053:Infection Control / Q000191:economics* / Q000331:legislation & jurisprudence; D016273:Occupational Exposure / Q000331:legislation & jurisprudence*; D014481:United States; D014489:United States Occupational Safety and Health Administration